FINWIRES · TerminalLIVE
FINWIRES

日立2025财年净归属收益预计增长30%

By

-- 日立(东京证券交易所代码:6501)2025财年归属于母公司股东的净利润同比增长30%,达到8023亿日元,而上年同期为6157亿日元。 该公司为电力和可再生能源企业提供系统解决方案。根据周一提交给东京证券交易所的文件显示,其每股净利润从上年同期的133.72日元增至176.63日元。 截至3月31日的整个财年,日立的营收同比增长8%,达到10.6万亿日元,而上年同期为9.783万亿日元。 在另一份披露文件中,日立计划根据盈利表现和其他因素,派发每股27日元的年终股息。 总额约为1215亿日元的股息预计将于5月由董事会最终确定,并将于6月4日支付。 公司预计2026财年净利润为8500亿日元,营业收入为11.1万亿日元。 日立计划在本财年派发每股28日元的期中股息。

Related Articles

Asia

Dongjiang Environmental's Loss Widens 2.7% in Q1

Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.

$HKG:0895$SHE:002672
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia

Zuoli Kechuang Logs Drop in Q1 Profit

Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.

$HKG:6866